The big difference is that typically drugs that ar

The big difference is that typically drugs that are in phase 2 do not yet have safety data. This is where the combo hiv indecation is really going to make a difference. All of these indications have very near term approval possibilities because the FDA already knows the safety. This is really an uncharted territory for comparison to other drugs.